Serine protease inhibitors (serpins) are a broadly distributed family of protease inhibitors that use a conformational change to inhibit target enzymes. Serpins can be divided into two categories. Clade A serpins include inflammatory response molecules such as SERPINA1 (antitrypsin), SERPINA3 (antichymotrypsin), SERPINA6 (corticosteroid-binding globulin), and SERPINA7 (thyroxine-binding globulin). Clade B includes inhibitory molecules such as SERPINB6(PI6), SERPINB9 (PI9), SERPINB3, (squamous cell carcinoma antigen-1), and SERPINB5 (maspin). Serines control crucial physiological processes, such as inflammation, coagulation, thrombosis and thrombolysis, and immune responses[1].
Belcesiran 是一种小干扰 RNA(siRNA),作为 α1 抗胰蛋白酶(A1AT)抑制剂,其作用机制是促使肝脏合成 A1AT 蛋白并将其释放到血液中。
Belcesiran 是一种小干扰 RNA(siRNA),作为 α1 抗胰蛋白酶(A1AT)抑制剂,其作用机制是促使肝脏合成 A1AT 蛋白并将其释放到血液中。
Belcesiran sodium scrambled negative control 是 Belcesiran sodium 的乱序阴性对照。
Crovozalpon(Compound 4)是一种α-1-抗胰蛋白酶抑制剂,可作为前体药物,用于研究与α-1-抗胰蛋白酶相关的疾病。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号